Martin Feighan

Martin Feighan is a Senior Bio-Analytical Scientist at Sterling Pharma Solutions since May 2022, leading the development and qualification of analytical methods for antibody and Antibody Drug Conjugates (ADCs). Prior experience includes roles at Pharmaron Biologics (UK) Ltd, where responsibilities spanned from analytical development to the optimization and validation of UHPLC and capillary electrophoresis methods. Martin began in the bioanalytical group at Bio Products Laboratory, focusing on analyzing product stability and developing new assays. Earlier positions included roles in brewery assistance and customer service, complemented by a summer project at the University of Nottingham investigating drug transporter interactions. Martin holds a Master's Degree in Biochemistry and Biological Chemistry from the University of Nottingham.